Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ni Catalyzed C H Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109665958B details a green ruthenium-catalyzed route to polysubstituted 1-naphthoic acids using air oxidation, offering significant cost and supply chain advantages for pharmaceutical intermediates.
Efficient Ru-catalyzed synthesis of N-sulfenyl-N-allyl amides. Mild conditions, high yield, scalable for pharma intermediates. Cost-effective supply chain solution.
Patent CN110724064B details a cost-effective nickel-catalyzed C-H activation method for synthesizing 2-cyclohexyl benzamide intermediates, offering significant supply chain advantages.
Patent CN117586310A reveals a novel Ni-Al bimetallic catalyst for enantioselective C(sp3)-H activation, offering cost reduction in pharmaceutical intermediates manufacturing and high-purity chiral nitrogen-containing heterocycles.
Patent CN112300061B details a novel Ru-catalyzed C-H acylation method using amides, offering a cost-effective and scalable route for high-purity pharmaceutical intermediates.
Efficient Ru-catalyzed C-H activation for 5-maleimide chromones. High yield, scalable process for pharmaceutical intermediates. Cost-effective supply chain solution.
Patent CN110724064A details a nickel-catalyzed route for 2-cyclohexylbenzamide, offering cost-effective pharma intermediate manufacturing with simplified supply chains.
Novel Ni-catalyzed route for benzofluorenone derivatives offers mild conditions and high yields for OLED and pharma applications ensuring supply stability.
Patent CN108101734A reveals efficient Ru-catalyzed synthesis. Offers cost reduction and supply chain reliability for electronic chemical manufacturing.
Patent CN106938983B reveals nickel-catalyzed olefin synthesis. Achieve cost reduction in fine chemical manufacturing with high-purity intermediates and scalable processes.
Patent CN114213384B reveals a ruthenium-catalyzed route for isocoumarins. This method offers significant supply chain stability and cost reduction advantages.
Discover the novel Ruthenium-catalyzed synthesis of 3-cyanoquinoline derivatives from patent CN113620875B. Offers cost reduction in API manufacturing and scalable green chemistry solutions.
Patent CN106336367B offers safe ruthenium-catalyzed route. Enhances supply chain reliability and reduces safety costs for fine chemical intermediate manufacturing.
Novel Ru-catalyzed C-H activation method for benzofuran acids. Green oxidant, scalable process for API intermediates and natural products like diptoindonesin G.
Novel ruthenium-catalyzed route offers high-purity pharmaceutical intermediates with simplified supply chain and cost reduction capabilities.
Novel Ni-catalyzed route for sulfur-containing isoindolinones offers high yield and green oxidation for reliable pharmaceutical intermediate supply chains and cost reduction.
Patent CN107641098A enables selective pyridone alkenylation using ruthenium catalysis. This method offers high yields and scalable production for pharmaceutical intermediate supply chains.
Patent CN107935812B reveals a green ruthenium-catalyzed route for polyaryl naphthalenes, offering significant cost reduction and scalability for optoelectronic and pharmaceutical manufacturing.
Novel ruthenium-catalyzed route offers high yield and safety for pharmaceutical intermediates, ensuring supply chain stability and cost efficiency.
Patent CN115286609B reveals efficient ruthenium-catalyzed route. Offers high yield and scalability for pharmaceutical intermediates supply chain optimization.